Europe OTC drugs Industry has been estimated at USD 26.34 billion in 2016 and is projected to reach USD 36.65 billion by 2021, at a CAGR of 6.83% during the forecast period from 2016 to 2021.
OTC drugs are the safe and effective drugs used for common ailments, and can be bought at the pharmacies and local stores, over the counter, without doctor’s prescription. Acetaminophen, aspirin and ibuprofen are the most common OTC drugs.
Easy accessibility, low cost, convenience, customer-empowering qualities are the benefiting the OTC drugs Industry in Europe.
Browse Industry data tables and in-depth TOC of the Europe Over the Counter (OTC) Drugs Industry to 2021 @ www.marketdataforecast.com/market-…drugs-market-511/
In Europe, public started showing pro-active approach towards the ailments and are resorting to lower-priced alternatives due to raising costs in healthcare.The cultural shift in public towards self-reliance is helping the pharma firms gain major acquisitions.
These are some of the drivers that are fueling the Industry growth. The Industry growth is hindered majorly due to the issue of drug substance abuse.
The European Industry is segmented based on product and geographically. The product Industry basically caters medicines in the categories like analgesics, cough, cold and flu products, dermatological products, gastrointestinal products, vitamins, minerals, weight loss products, sleep aids, ophthalmic products, smoking cession aids and other products.
More than half of the Industry share belongs to categories like Analgesics, Cough, Cold & Flu, Dermatological and gastrointestinal categories.
Free sample of the report is available @ www.marketdataforecast.com/market-…11/request-sample
In the EU, the major contributors to the Industry are Germany and France. Annual growth for developed nations is decreasing, while for the developing nations like Poland, the growth is stable.
Ukraine and Bulgaria are the most rapidly developing Industrys. The governments in the EU are attempting to shift the costs to customers and are trying to save doctors’ and pharmacists’ resource costs.
GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi and Takeda and are the top companies that contribute to North American OTC drugs Industry. Loss of patent protection is leading the companies switch to OTC.
Enquire about report @ www.marketdataforecast.com/market-…arket-511/inquire
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Europe OTC Drugs Industry: Segmentation
- Product Type
- o Analgesics
- o Cough, Cold and Flu Products
- o Vitamins and Minerals
- o Dermatological Products
- o Gastrointestinal Products
- o Ophthalmic Products
- o Sleep Aid Products
- o Weight Loss/Diet Products
- o Others
- By Formulation Type
- o Tablets
- o Liquids
- o Ointments
- o Sprays
- Distribution Channels
- o Pharmacies
- o SuperIndustrys/HyperIndustrys
- o Convenience stores
- o Others (Online Drug Stores)
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Access report@ www.marketdataforecast.com/market-…/request-discount
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!